Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Interobserver variation in parotid gland delineation: a study of its impact on intensity-modulated radiotherapy solutions with a systematic review of the literature.

Loo SW, Martin WM, Smith P, Cherian S, Roques TW.

Br J Radiol. 2012 Aug;85(1016):1070-7. doi: 10.1259/bjr/32038456. Review.

2.

Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.

Ho KF, Marchant T, Moore C, Webster G, Rowbottom C, Penington H, Lee L, Yap B, Sykes A, Slevin N.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e375-82. doi: 10.1016/j.ijrobp.2011.07.004. Epub 2011 Dec 22.

PMID:
22197229
3.

Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.

van de Water TA, Lomax AJ, Bijl HP, Schilstra C, Hug EB, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e313-9. doi: 10.1016/j.ijrobp.2011.05.005. Epub 2011 Jun 25.

PMID:
21708427
4.

Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines.

Guerrero Urbano MT, Clark CH, Kong C, Miles E, Dearnaley DP, Harrington KJ, Nutting CM, PARSPORT Trial Management Group.

Clin Oncol (R Coll Radiol). 2007 Oct;19(8):604-13. Epub 2007 Aug 13.

PMID:
17706404
5.

Comparison of two different IMRT planning techniques in the treatment of nasopharyngeal carcinoma. Effect on parotid gland radiation doses.

Uzel EK, Karaçam S, Eliçin O, Uzel O.

Strahlenther Onkol. 2013 Jul;189(7):552-8. doi: 10.1007/s00066-013-0344-z. Epub 2013 Jun 9.

PMID:
23748231
6.

Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience.

Claus F, Duthoy W, Boterberg T, De Gersem W, Huys J, Vermeersch H, De Neve W.

Oral Oncol. 2002 Sep;38(6):597-604.

PMID:
12167438
7.

Parotid gland sparing with helical tomotherapy in head-and-neck cancer.

Voordeckers M, Farrag A, Everaert H, Tournel K, Storme G, Verellen D, De Ridder M.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):443-8. doi: 10.1016/j.ijrobp.2011.11.070. Epub 2012 Jul 25.

PMID:
22836056
8.

Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.

Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, Worden FP, Urba S, Lin A, Schipper MJ, Wolf GT.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):28-42.

PMID:
15093896
9.

FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism.

Roach MC, Turkington TG, Higgins KA, Hawk TC, Hoang JK, Brizel DM.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):321-6. doi: 10.1016/j.ijrobp.2010.08.055. Epub 2010 Oct 27.

PMID:
21030160
10.

Impact of residual setup error on parotid gland dose in intensity-modulated radiation therapy with or without planning organ-at-risk margin.

Delana A, Menegotti L, Bolner A, Tomio L, Valentini A, Lohr F, Vanoni V.

Strahlenther Onkol. 2009 Jul;185(7):453-9. doi: 10.1007/s00066-009-1888-9. Epub 2009 Aug 28.

PMID:
19714307
11.

Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer.

Fiorentino A, Caivano R, Metallo V, Chiumento C, Cozzolino M, Califano G, Clemente S, Pedicini P, Fusco V.

Br J Radiol. 2012 Oct;85(1018):1415-9. doi: 10.1259/bjr/30678306. Epub 2012 May 9.

12.

Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer.

Cannon DM, Lee NY.

Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):660-5. Epub 2007 Nov 26.

PMID:
18037580
13.

Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.

Hunter KU, Fernandes LL, Vineberg KA, McShan D, Antonuk AE, Cornwall C, Feng M, Schipper MJ, Balter JM, Eisbruch A.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):676-82. doi: 10.1016/j.ijrobp.2013.07.040. Epub 2013 Sep 10.

14.

Co-registration of cone beam CT and planning CT in head and neck IMRT dose estimation: a feasible adaptive radiotherapy strategy.

Yip C, Thomas C, Michaelidou A, James D, Lynn R, Lei M, Guerrero Urbano T.

Br J Radiol. 2014 Feb;87(1034):20130532. doi: 10.1259/bjr.20130532. Epub 2013 Nov 28.

15.

Normal tissue anatomy for oropharyngeal cancer: contouring variability and its impact on optimization.

Feng M, Demiroz C, Vineberg KA, Eisbruch A, Balter JM.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e245-9. doi: 10.1016/j.ijrobp.2012.03.031. Epub 2012 May 12.

16.

Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience.

Chao KS, Low DA, Perez CA, Purdy JA.

Int J Cancer. 2000 Apr 20;90(2):92-103.

17.

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.

Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87.

PMID:
15380569
18.

The dose to the parotid glands with IMRT for oropharyngeal tumors: the effect of reduction of positioning margins.

van Asselen B, Dehnad H, Raaijmakers CP, Roesink JM, Lagendijk JJ, Terhaard CH.

Radiother Oncol. 2002 Aug;64(2):197-204.

PMID:
12242130
19.
20.

Intensity-modulated radiotherapy: is xerostomia still prevalent?

Chambers MS, Garden AS, Rosenthal D, Ahamad A, Schwartz DL, Blanco AI, Chao KS, Morrison WH, Ang KK, Weber RS.

Curr Oncol Rep. 2005 Mar;7(2):131-6. Review.

PMID:
15717947
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk